REPORTS OF SUSPECTED HYDROCORTISONE SIDE EFFECTS / ADVERSE REACTIONS
Below is a sample of reports where side effects / adverse reactions may be related to Hydrocortisone. The information is not vetted and should not be considered as verified clinical evidence.
Possible Hydrocortisone side effects / adverse reactions in 54 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2011-10-03
Patient: 54 year old male
Reactions: Fungal Infection, Pyrexia, Neutropenia, Septic Shock
Adverse event resulted in: death
Suspect drug(s):
Cytarabine
Dosage: 30 mg, unk
Idarubicin HCL
Dosage: unk ukn, unk
Hydrocortisone
Dosage: 12.5 mg, unk
Methotrexate
Dosage: 12.5 mg, unk
Etoposide
Dosage: unk ukn, unk
Other drugs received by patient: Amphotericin B
Possible Hydrocortisone side effects / adverse reactions in 90 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-04
Patient: 90 year old male
Reactions: Orthostatic Hypotension, Death, Haematocrit Decreased, Pleural Effusion, Drug Administration Error, Hypoxia, Blood Creatinine Increased, Blood Glucose Increased, Hydronephrosis, Dyspnoea, Urinary Tract Infection, Renal Failure, Sepsis, Dehydration, Gait Disturbance, Asthenia
Adverse event resulted in: death
Suspect drug(s):
Doxazosin Mesylate
Indication: Bladder Disorder
Hydrocortisone
Indication: Prostate Cancer
Other drugs received by patient: Carvedilol; Ketoconazole
Possible Hydrocortisone side effects / adverse reactions in 13 year old male
Reported by a physician from United States on 2011-10-04
Patient: 13 year old male weighing 39.6 kg (87.1 pounds)
Reactions: Confusional State, Akathisia, Anxiety, Pruritus, Chills, Pain, Anger, Memory Impairment, Paraesthesia
Suspect drug(s):
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2011-09-08
Hydrocortisone
Dosage: unk
Indication: B Precursor Type Acute Leukaemia
Start date: 2011-09-08
Vincristine
Dosage: 1.5 mg/m2, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2011-09-08
Methotrexate
Dosage: unk
Indication: B Precursor Type Acute Leukaemia
Start date: 2011-09-08
Prednisone
Dosage: 20 mg/m2, cyclic
Administration route: Oral
Indication: B Precursor Type Acute Leukaemia
Start date: 2011-09-08
Cytarabine
Dosage: unk
Indication: B Precursor Type Acute Leukaemia
Doxorubicin HCL
Dosage: 60 mg/m2, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2011-09-08
End date: 2011-09-09
Pegaspargase
Dosage: 2500 unk, unk
Indication: B Precursor Type Acute Leukaemia
Start date: 2011-09-08
Other drugs received by patient: Bactrim; Benadryl; Ranitidine; Ativan; Zofran; Scopolamine
|